{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:51:51Z","timestamp":1790077911122,"version":"4.0.1"},"reference-count":38,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T00:00:00Z","timestamp":1288310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[2011,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The aim of this study was to evaluate the pharmacokinetics and efficacy of posaconazole (PSC) in combination with granulocyte colony\u2010stimulating factor (G\u2010CSF) in a neutropaenic murine model of disseminated zygomycosis (mucormycosis) due to<jats:italic>Rhizopus microsporus<\/jats:italic>. Male BALB\/c mice were rendered neutropaenic with cyclophosphamide (200\u2003mg\u2003kg<jats:sup>\u22121<\/jats:sup>, intraperitoneally) administered on days \u22121 and +5 postinfection. Mice were infected with<jats:italic>R. microsporus<\/jats:italic>(5\u2003\u00d7\u200310<jats:sup>4<\/jats:sup>spores\u2003ml<jats:sup>\u22121<\/jats:sup>) intravenously. Mice were treated with PSC (40\u2003mg\u2003kg<jats:sup>\u22121\u2003<\/jats:sup>day<jats:sup>\u22121<\/jats:sup>by gavage) or G\u2010CSF (300\u2003\u03bcg\u2003kg<jats:sup>\u22121\u2003<\/jats:sup>day<jats:sup>\u22121<\/jats:sup>subcutaneously) or with the combination of PSC and G\u2010CSF. The fungal burden was assessed by culturing the brain, liver, kidneys and lungs. Blood levels of PSC were measured by high performance liquid chromatography. The survival rates were 33%, 27% and 31% for PSC\u2010treated\u2010, G\u2010CSF\u2010treated\u2010 and PSC\u2003+\u2003G\u2010CSF\u2010treated mice, respectively, as compared to 18% for the controls (<jats:italic>P\u2003<\/jats:italic>=\u2003NS). PSC monotherapy and combination therapy significantly reduced the fungal burden in the kidneys, but not in the rest of the organs. Combination therapy was not superior to PSC monotherapy in terms of either survival or reduction in fungal burden. Serum concentrations of PSC were well\u2010above the MIC of PSC for the particular isolate. PSC monotherapy has a modest efficacy against<jats:italic>R. microsporus<\/jats:italic>in reducing fungal burden in neutropaenic mice. Combining G\u2010CSF with PSC does not substantially affect the antifungal activity of PSC.<\/jats:p>","DOI":"10.1111\/j.1439-0507.2010.01958.x","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T14:04:19Z","timestamp":1288361059000},"source":"Crossref","is-referenced-by-count":19,"title":["Antifungal activity of posaconazole and granulocyte colony\u2010stimulating factor in the treatment of disseminated zygomycosis (mucormycosis) in a neutropaenic murine model"],"prefix":"10.1111","volume":"54","author":[{"given":"Stamatis","family":"Saoulidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Simitsopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dalakiouridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Joseph","family":"Wheat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Papaioannidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Roilides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,29]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/oso\/9780195148091.003.0015","volume-title":"Clinical Mycology","author":"Ibrahim AS","year":"2003"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.13.2.236"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2006.06.003"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(02)00037-5"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/432579"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm429"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.3.556-569.2005"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.09.015"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2006.01295.x"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565110-00007"},{"key":"e_1_2_7_12_2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1128\/AAC.44.1.226-229.2000","article-title":"In vitro activities of the new antifungal triazole SCH56592 against common and emerging yeast pathogens","volume":"44","author":"Barchiesi F","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00163-06"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.11.3647-3650.2003"},{"key":"e_1_2_7_15_2","first-page":"634","article-title":"Safety of long\u2010term oral posaconazole use in the treatment of refractory invasive fungal infections","volume":"41","author":"Raad II","year":"2006","journal-title":"Clin Infect Dis"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/500212"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.1.126-133.2006"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/08977190500055836"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2006.05.002"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2001.tb00011.x"},{"key":"e_1_2_7_21_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00277-003-0628-y","article-title":"Clinical applications of granulocyte colony\u2010stimulating factor: an update and summary","volume":"82","author":"Hubel K","year":"2003","journal-title":"Ann Hematol"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05498.x"},{"key":"e_1_2_7_23_2","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi\u2010Second Edition: Approved Standard M38\u2010A2","author":"National Committee for Clinical Laboratory Standards","year":"2008"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.1.137-142.2004"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00452-07"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1086\/314679"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.4.1185-1193.1993"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.2003.00004.x"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.4.907"},{"key":"e_1_2_7_30_2","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1128\/AAC.42.9.2299","article-title":"Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: effects of granulocyte colony\u2010stimulating factor and granulocyte\u2010macrophage colony\u2010stimulating factor","volume":"42","author":"Vora S","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.7.2310-2312.2002"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00628-08"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01124-08"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01026-09"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.3.727-731.2000"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.8.3154-3158.2004"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00456-09"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.10.2467"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.10.3801-3805.2004"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.2010.01958.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1439-0507.2010.01958.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T22:08:10Z","timestamp":1711922890000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.2010.01958.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,29]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["10.1111\/j.1439-0507.2010.01958.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.2010.01958.x","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,29]]}}}